ASA
GMED icon

Axxion S.A.’s Globus Medical GMED Stock Holding History

Axxion S.A.’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Buy
+3,910
New +$332K 0.02% 303

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JTL
Jupiter Topco LLC New York $245B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Axxion S.A.'s GMED Position: Q2 2026 in Review

Axxion S.A. opened a new position in Globus Medical (GMED) in Q2 2026: 3,910 shares worth $309K. The stake represents 0.02% of the portfolio and ranks #303 among its holdings.

566 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Axxion S.A. held 3,910 shares of Globus Medical worth $309K as of Q2 2026.
  • Globus Medical was a new Axxion S.A. position in Q2 2026.
  • Globus Medical made up 0.02% of Axxion S.A.'s portfolio in Q2 2026, its #303 holding.
  • 566 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Axxion S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.